TABLE OF CONTENTS
Volume 25, Issue 29 (6 July 2006)
Original Articles
Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein
M Vogt, K Butz, S Dymalla, J Semzow and F Hoppe-Seyler
Oncogene 25: 4009-4015; advance online publication, February 6, 2006; doi:10.1038/sj.onc.1209429
The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-
inducibility of TAP1 and LMP2
T Hayashi, Y Kobayashi, S Kohsaka and K Sano
Oncogene 25: 4016-4026; advance online publication, February 13, 2006; doi:10.1038/sj.onc.1209434
Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis
K A Honeycutt, Z Chen, M I Koster, M Miers, J Nuchtern, J Hicks, D R Roop and J M Shohet
Oncogene 25: 4027-4032; advance online publication, March 6, 2006; doi:10.1038/sj.onc.1209435
Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity
S Carujo, J M Estanyol, A Ejarque, N Agell, O Bachs and M J Pujol
Oncogene 25: 4033-4042; advance online publication, February 13, 2006; doi:10.1038/sj.onc.1209433
Cooperative cell transformation by Myc/Mil(Raf) involves induction of AP-1 and activation of genes implicated in cell motility and metastasis
M Hartl, A I Karagiannidis and K Bister
Oncogene 25: 4043-4055; advance online publication, February 20, 2006; doi:10.1038/sj.onc.1209441
Regulation of PUMA-
by p53 in cisplatin-induced renal cell apoptosis
M Jiang, Q Wei, J Wang, Q Du, J Yu, L Zhang and Z Dong
Oncogene 25: 4056-4066; advance online publication, February 20, 2006; doi:10.1038/sj.onc.1209440
Fate and characterization of circulating tumor cells in a NOD/SCID mouse model of human hepatocellular carcinoma
O Scatton, F Chiappini, P Riou, A Marconi, R Saffroy, M-P Bralet, D Azoulay, C Boucheix, B Debuire, G Uzan and A Lemoine
Oncogene 25: 4067-4075; advance online publication, February 20, 2006; doi:10.1038/sj.onc.1209430
Transforming growth factor alpha acts as a gliatrophin for mouse and human astrocytes
A Sharif, V Prévot, F Renault-Mihara, C Allet, J-M Studler, B Canton, H Chneiweiss and M-P Junier
Oncogene 25: 4076-4085; advance online publication, March 13, 2006; doi:10.1038/sj.onc.1209443
Smad6 is a protein kinase X phosphorylation substrate and is required for HL-60 cell differentiation
D Glesne and E Huberman
Oncogene 25: 4086-4098; advance online publication, February 20, 2006; doi:10.1038/sj.onc.1209436
The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10
L Fröhlich Archangelo, J Gläsner, A Krause and S K Bohlander
Oncogene 25: 4099-4109; advance online publication, February 20, 2006; doi:10.1038/sj.onc.1209438
Short Communications
The tumor suppressor p16Ink4a regulates T lymphocyte survival
T Bianchi, N Rufer, H R MacDonald and M Migliaccio
Oncogene 25: 4110-4115; advance online publication, February 20, 2006; doi:10.1038/sj.onc.1209437
Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer
O Aguilera, M F Fraga, E Ballestar, M F Paz, M Herranz, J Espada, J M García, A Muñoz, M Esteller and J M González-Sancho
Oncogene 25: 4116-4121; advance online publication, February 20, 2006; doi:10.1038/sj.onc.1209439
Loss of Sef (similar expression to FGF) expression is associated with high grade and metastatic prostate cancer
S Darby, K Sahadevan, M M Khan, C N Robson, H Y Leung and V J Gnanapragasam
Oncogene 25: 4122-4127; advance online publication, February 13, 2006; doi:10.1038/sj.onc.1209428
Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
E De la Cueva, I García-Cao, M Herranz, P López, P García-Palencia, J M Flores, M Serrano, J Fernández-Piqueras and J Martín-Caballero
Oncogene 25: 4128-4132; advance online publication, February 6, 2006; doi:10.1038/sj.onc.1209432
